The relative staining intensity for SLC16A1 was weak (2 cases) for normal tissue and weak (2 cases), moderate (5 cases) and strong (5 cases) for pancreatic cancer cases (Fig. 5C). This evidence concerns the gene SLC16A1 and familial pancreatic carcinoma.